Search

Universidade de Bras?lia. Faculdade de Medicina. Laborat?rio Multidisciplinar de Pesquisa em Doen?a de Chagas. Bras?lia, DF, Brasil. Universidade de Bras?lia. Faculdade de Medicina. Laborat?rio Multidisciplinar de Pesquisa em Doen?a de Chagas. Bras?lia, DF, Brasil. Universidade de Bras?lia. Faculdade de Medicina. Laborat?rio Multidisciplinar de Pesquisa em Doen?a de Chagas. Bras?lia, DF, Brasil. Universidade de Bras?lia. Faculdade de Medicina. Laborat?rio Multidisciplinar de Pesquisa em Doen?a de Chagas. Bras?lia, DF, Brasil. Universidade de Bras?lia. Faculdade de Medicina. Laborat?rio Multidisciplinar de Pesquisa em Doen?a de Chagas. Bras?lia, DF, Brasil. Minist?rio da Sa?de. Secretaria de Vigil?ncia em Sa?de. Instituto Evandro Chagas. Ananindeua, PA, Brasil. Minist?rio da Sa?de. Secretaria de Vigil?ncia em Sa?de. Instituto Evandro Chagas. Ananindeua, PA, Brasil. Universidade de Bras?lia. Faculdade de Medicina. Laborat?rio Multidisciplinar de Pesquisa em Doen?a de Chagas. Bras?lia, DF, Brasil. Universidade de Bras?lia. Faculdade de Medicina. Laborat?rio Multidisciplinar de Pesquisa em Doen?a de Chagas. Bras?lia, DF, Brasil. Universidade de Bras?lia. Faculdade de Medicina. Laborat?rio Multidisciplinar de Pesquisa em Doen?a de Chagas. Bras?lia, DF, Brasil. Universidade de Bras?lia. Faculdade de Medicina. Laborat?rio Multidisciplinar de Pesquisa em Doen?a de Chagas. Bras?lia, DF, Brasil. Universidade de Bras?lia. Faculdade de Medicina. Laborat?rio Multidisciplinar de Pesquisa em Doen?a de Chagas. Bras?lia, DF, Brasil. BACKGROUND: The Trypanosoma cruzi infection endemic in Latin America has now spread to several countries across four continents; this endemic involves triatomine vector-free protists. We hypothesised that the sexual transmission of T. cruzi contributes to the ongoing spread of Chagas disease. OBJECTIVES: A short-term longitudinal study was conducted to evaluate this hypothesis. METHODS: The study population comprised 109 subjects from four families, among whom 21 had been diagnosed with acute Chagas disease by direct parasitological analysis. Blood mononuclear cells and serum samples were obtained from each study subject once per year for three consecutive years. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence serological examinations were used to detect specific T. cruzi antibodies. Polymerase chain reaction of T. cruzi DNA revealed 188-nucleotide bands, which hybridised to a specific radiolabelled probe and were confirmed by cloning and sequencing. RESULTS: Three independent assessments at different time points revealed T. cruzi nuclear DNA footprints in 76% (83/109) of the study population with active infection. In contrast, the ELISA and indirect immunofluorescence assays detected the T. cruzi antibody in 28.4% (31/109) of the study samples. Moreover, the semen from 82.6% (19/23) of subjects people revealed harboured the 188- bp base pair T. cruzi footprint. Interestingly, the ejaculates of nuclear DNA-positive Chagas patient transmitted the T. cruzi upon peritoneal injection or infusion in the vagina of mice, and amastigotes were detected in the skeletal muscle, myocardium, vas deferens, and uterine tube. MAIN CONCLUSIONS: T. cruzi infections can be transmitted from females or males to na?ve mates through intercourse, and progeny showed discrepancies between the ratios of nuclear DNA footprints and specific antibody that can be explained by the tolerance attained during early embryo growth. Additional studies are needed to develop drugs to eradicate the infections. Additionally, the importance of a vigorous education, information, and communication program to prevent sexually transmitted Chagas disease in humans cannot be underemphasised.

Foundation for the Advancement of Science (FAPDF) ; National Research Council, Ministry of Science and Technology (CNPq/MCT) ; Agency for Training Human Resources, Ministry of Education (CAPES/ME), Brazil . Universidade de Brasilia. Faculdade de Medicina. Multidisciplinar de Pesquisa em Doen?as de Chagas. Brasilia, DF, Brazil. Universidade de Brasilia. Faculdade de Medicina. Multidisciplinar de Pesquisa em Doen?as de Chagas. Brasilia, DF, Brazil. Universidade de Brasilia. Faculdade de Medicina. Multidisciplinar de Pesquisa em Doen?as de Chagas. Brasilia, DF, Brazil. Universidade de Brasilia. Faculdade de Medicina. Multidisciplinar de Pesquisa em Doen?as de Chagas. Brasilia, DF, Brazil. Minist?rio da Sa?de. Secretaria de Vigil?ncia em Sa?de. Instituto Evandro Chagas. Ananindeua, PA, Brasil. Universidade de Brasilia. Faculdade de Medicina. Multidisciplinar de Pesquisa em Doen?as de Chagas. Brasilia, DF, Brazil. American trypanosomiasis is transmitted to humans by triatomine bugs through the ingestion of contaminated food, by blood transfusions or accidently in hospitals and research laboratories. In addition, the Trypanosoma cruzi infection is transmitted congenitally from a chagasic mother to her offspring, but the male partner's contribution to in utero contamination is unknown. The findings of nests and clumps of amastigotes and of trypomastigotes in the theca cells of the ovary, in the goniablasts and in the lumen of seminiferous tubules suggest that T. cruzi infections are sexually transmitted. The research protocol herein presents the results of a family study population showing parasite nuclear DNA in the diploid blood mononuclear cells and in the haploid gametes of human subjects. Thus, three independent biological samples collected one year apart confirmed that T. cruzi infections were sexually transmitted to progeny. Interestingly, the specific T. cruzi antibody was absent in the majority of family progeny that bore immune tolerance to the parasite antigen. Immune tolerance was demonstrated in chicken refractory to T. cruzi after the first week of embryonic growth, and chicks hatched from the flagellate-inoculated eggs were unable to produce the specific antibody. Moreover, the instillation of the human semen ejaculates intraperitoneally or into the vagina of naive mice yielded T. cruzi amastigotes in the epididymis, seminiferous tubule, vas deferens and uterine tube with an absence of inflammatory reactions in the immune privileged organs of reproduction. The breeding of T. cruzi-infected male and female mice with naive mates resulted in acquisition of the infections, which were later transmitted to the progeny. Therefore, a robust education, information and communication program that involves the population and social organizations is deemed necessary to prevent Chagas disease.

Objective: To contribute to the discussion on the research findings indicating the sexual transmission of American trypanosomiasis and Chagas disease in humans. Methods: A review of the literature was performed to investigate the routes of transmission of Trypanosoma cruzi parasites and to evaluate the distribution of Chagas disease, which is now found across five continents. Results: The epidemiological profile of American trypanosomiasis, which is still considered a neglected disease of the poor people of Latin America, has changed over time. A family-based study demonstrated that the blood protozoan T. cruzi can be transmitted sexually from infected males and females to naïve mates. Conclusions: Evidence that Chagas disease can be transmitted sexually, coupled with the migration of individuals with Chagas disease to previously non-endemic countries and increased travel to endemic countries, has implications for public health. Improved screening of blood supplies and prenatal care are required to prevent congenital spread. Keywords: Trypanosoma cruzi, Chagas disease, Sexual transmission, Humans, Mouse model system, Vertical transmission, Diagnosis, Prevention

Ruthenium (II) complex-sensitized TiO 2 electrodes were chemically coated with NH 2 -terminated poly(amidoamide) dendrimers generation 4.0 in order to improve the performance of dye-sensitized solar cells using these photoanodes. The presence of dendrimers in these photodevices produced a global photovoltaic conversion efficiency of 6.78%, which was higher than that obtained for photocells without them (5.43%). The experimental results indicated that this treatment of the dye-sensitized TiO 2 electrodes allowed for controlling the concentrations of I 3 − anions and Li + cations into the dendrimers-modified dyed-TiO 2 pores during operation of the photocells. Consequently, the charge interception reaction and the charge accumulation process at the conduction band of the TiO 2 electrodes were simultaneously balanced by the establishment of I 2 ···NH 2 , NH···I − and C = O···Li + bonds at the branches of the confined dendrimers for increasing their global conversion efficiency.

Background: To assess Guillain-Barré syndrome (GBS) incidence we relied on the Italian Network for the study of GBS (ITANG) established in 2010 in 7 Italian regions to analyse the association between influenza vaccination and GBS. Methods: All individuals aged ≥18 years, presenting with clinical manifestations that suggested GBS according to the universally accepted Asbury's diagnostic criteria (1990) were prospectively notified to a centralised database by ITANG neurologists over the period October 1, 2010-September 30, 2011. Through a telephone survey, 9 trained interviewers followed up the cases to diagnosis and then for 1 year since hospital discharge. Validation of case reporting was performed with the support of administrative data in 5 regions. Results: We found 365 cases fulfilling the definition for GBS or one of its variants over 19,846,068 population ≥18 years of age, yielding an annual incidence rate of 1.84 per 100,000 (95% CI 1.65-2.03), 2.30 (95% CI 1.99-2.60) in men and 1.41 (95% CI 1.18-1.64) in women. A highly significant peak of incidence was observed in February 2011 as compared to reference month (September 2011, rate ratio 3.3:1, p < 0.01). Conclusions: In Italy, GBS incidence was among the highest reported in Europe and higher than previously observed in Italian studies.

Background: The contribution of genetic variants underlying the susceptibility to different clinical courses of multiple sclerosis (MS) is still unclear. Objective: The aim of the study is to evaluate and compare the proportion of liability explained by common SNPs and the genetic burden of MS-associated SNPs in progressive onset (PrMS) and bout-onset (BOMS) cases. Methods: We estimated the proportion of variance in disease liability explained by 296,391 autosomal SNPs in cohorts of Italian PrMS and BOMS patients using the genome-wide complex trait analysis (GCTA) tool, and we calculated a weighted genetic risk score (wGRS) based on the known MS-associated loci. Results: Our results identified that common SNPs explain a greater proportion of phenotypic variance in BOMS (36.5%±10.1%) than PrMS (20.8%±6.0%) cases, and a trend of decrease was observed when testing primary progressive (PPMS) without brain MRI inflammatory activity ( p = 7.9 × 10−3). Similarly, the wGRS and the variance explained by MS-associated SNPs were higher in BOMS than PPMS in males (wGRS: 6.63 vs 6.51, p = 0.04; explained variance: 4.8%±1.5% vs 1.7%±0.6%; p = 0.05). Conclusions: Our results suggest that the liability of disease is better captured by common genetic variants in BOMS than PrMS cases. The absence of inflammatory activity and male gender further raise the difference between clinical courses.

Introduction Depression and anxiety are common among patients with multiple sclerosis (MS) and are frequently present at the time of MS diagnosis. Methods POSIDONIA was a 12-month, observational, prospective study conducted in Italy to evaluate the impact of disease-modifying treatment (DMT) on emotional burden in patients with recently-diagnosed MS. The Hospital Anxiety and Depression Scale (HADS), specifically HADS anxiety (HADS-A) and depression (HADS-D) subscale scores, the Short-Form 36 Health Survey (SF-36) and the Impact of Event Scale – Revised (IES-R) were used to measure patient-reported outcomes. The Hamilton Depression Rating Scale (HDRS), HDRS-17, was used as a measure of healthcare provider-reported outcomes. The primary study outcome was change from baseline in feelings of anxiety and depression over 12 months (via HADS). Results Of 250 enrolled patients, 222 (88.8%) completed the study. At baseline, mean HADS total, HADS-A and HADS-D subscale scores were within the normal range. There were no significant changes over time in mean HADS total and HADS-A and HADS-D subscale scores, although the subgroup of patients with baseline scores indicative of anxiety or depression tended to improve over time. Both the HDRS and IES-R total scores improved over time, but there were no statistically significant changes in SF-36. Conclusion In the patient population of the POSIDONIA study depression and anxiety were present in a minority of patients thus not allowing to detect the impact of starting DMT. However DMT appears to have a positive effect in patients with measurable anxiety or depression at baseline.

A2. Growth models from solutions B1. Nanomaterials B1. Polyamidoamine dendrimers B2. Semiconducting cadmium compounds abstract CdS nanoparticles (CdS-nps) were synthesized employing charged and neutral polyamidoamide (PAMAM) dendrimers (generation G3.5, G4.0 and G4.0-OH with 64 -COO � ,- NH 3 and -OH peripheral groups, respectively) as templates. The morphological characterization of CdS-nps was carried out using TEM measurements that showed spherical nanoparticles characterized by average diameter values between 3.6 and 4.7 nm. Using UV-vis experiments, CdS-nps formation was evaluated using a diffusion controlled growth model where the S 2� diffusion coefficient throughout the external and internal functional groups of dendrimers was found to be an important parameter. In this way, the results indicate that nanoparticle formation is primarily affected by the charged nature of the external functional groups of the dendrimer template.

In this work, electrochemical generation of ferrate ion (FeO4-2) using a prototype of batch electrochemical reactor with agitation was studied. The anode used was a piece of steel tube (ASTM-A53) of 2 inches of nominal diameter and the cathode used was a steel bar of 0.5 inches. In the electrochemical reactor we did not use membranes, in order to diminish production costs and to make it a much more competitive and attractive process. Two different electrolytes were tested as reactant medium in the system: NaOH (10 M) and KOH (10 M). A current density of 53.62 mA/cm2 was applied with respect to the anode during a period of time of two hours. Afterwards the concentration of ferrate was determined in function of time using a spectroscopy method. It was found that the concentration of ferrate is higher in NaOH as reactant medium than KOH.

To investigate whether a group of Italian children and adolescents who were diagnosed to have metabolic syndrome (MS) according to a new ethnic age and gender specific definition had, in comparison with a control group, other signs and metabolic risk factors which are commonly associated with MS.The cross-sectional study population included 300 subjects (51% boys, age range 6-14 years), who were divided into 2 groups according to the presence of MS, diagnosed on the basis of 3/5 factors derived from the age and gender specific quantile distribution of MS components in a large regional Italian population survey (Calabrian Sierras Community Study, CSCS). In all subjects the following data were collected: anthropometric measures, blood pressure, liver function, C-reactive protein (hsCRP), uric acid blood levels, lipid and glucose profile. Triglycerides/HDL-cholesterol (TG/HDL-C) ratio was calculated.There were 38 subjects (13%) with MS, who had higher indices of growth and fat distribution and higher blood levels of uric acid, alanine aminotransferase and gamma-glutamyltransferase. TG/HDL ratio was higher (median 3.11 vs. 1.14, p = 0.00001) in MS subjects who had lower apolipoprotein A and higher apolipoprotein B and non-HDL-C levels. hsCRP was not different between groups.Our ethnic age and gender specific definition of MS in Italian children and adolescents was able to identify in a youth group different cardiometabolic risk factors related to insulin resistance, endothelial damage and nonalcoholic fatty liver disease, which are commonly associated with MS diagnosis.

The MightyMedic (Multidisciplinary International Group for Hemapheresis TherapY and MEtabolic DIsturbances Contrast) Working Group has been founded in 2013. The leading idea was to establish an international network of interdisciplinary nature aimed at working to cross national borders research projects, clinical trials, educational initiatives (meetings, workshops, summer schools) in the field of metabolic diseases, namely hyperlipidemias, and diabetes, preventive cardiology, and atherosclerosis. Therapeutic apheresis, its indications and techniques, is a parallel field of investigation. The first on-line survey of the Group has been completed in the first half of 2014. The survey included # 24 Centers in Italy, Germany, Greece, UK, Sweden, Japan and USA. Relevant data have been collected on current practice in diagnosis, therapy and follow-up of dyslipidemias. 240 subjects with hyperlipidemia and treated with lipoprotein apheresis have been reported in the survey, but a large percentage of patients (35%) who could benefit from this therapeutic option are still treated by conventional drug approach. Genetic molecular diagnosis is performed in only 33% of patients while Lipoprotein(a) (Lp(a)) is included in cardiovascular disease risk assessment in 71% of participating Centers. New detailed investigations and prospective multicenter studies are needed to evaluate changes induced by the impact of updated indications and strategies, as well as new treatment options, targeting standardization of therapeutic and diagnostic approaches. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

We aimed to evaluate the safety and MRI efficacy of interferon beta-1b (IFNbeta-1b) 375 microg (subcutaneously [sc] every other day [eod]) in relapsing-remitting multiple sclerosis (RRMS) patients with a suboptimal response to IFNbeta-1b 250 microg, i.e., with MRI activity or relapses. The OPTimization of Interferon for MS (OPTIMS) study was a prospective multicenter randomized phase 2 trial comprising a 6-month run-in phase (to identify suboptimal responders) and a 6-month randomized phase of open-label clinical and blinded MRI follow-up. During run-in all patients were treated with IFNbeta-1b 250 microg sc eod; during the study phase suboptimal treatment responders were randomized either to IFNbeta-1b 250 or 375 microg sc eod. Primary outcome was the proportion of patients without MRI activity during study Months 9-12 according to the intention-to-treat principle. 216 RRMS patients entered the study: 83 suboptimal responders were identified and randomized, 7 refused to continue treatment, 76 were included in the analysis. More patients treated with 375 microg had no MRI activity at Months 9-12 (30/36 vs.16/40; relative risk, 0.28; 95 % confidence interval, 0.08-0.47; p = 0.0001). Sensitivity analysis ("worst case scenario") confirmed the results. No new or unexpected adverse events were observed, but there was a trend towards more withdrawals in the 375 microg group. Increasing the dose of IFNbeta-1b from 250 microg to 375 microg is a successful strategy for reducing subclinical signs of disease activity in RRMS patients. Further studies are needed to show whether this dose may also improve clinical efficacy.

Objective: To prospectively validate MRI activity and neutralising anti-interferon antibody (NAb) during the first 6 months of interferon β treatment as response indicators in multiple sclerosis (MS). Methods: Patients with relapsing–remitting MS were followed during the first 2 years of treatment. Neurological assessments were performed every 3 months or when a relapse was suspected. MRI scans performed at baseline and at 3, 4, 5 and 6 months after the start of treatment were assessed centrally for disease activity: new T2 or gadolinium enhancing T1 lesions. NAb were assessed using the MxA protein assay; positivity was defined as two consecutive titres ⩾20 NU/ml. We evaluated the predictivity of an active scan, NAb positivity, or both, during the first 6 months of treatment, on the occurrence of clinical disease activity in the following 18 months. Results: 147 patients were assessed at 16 centres. Predictivity parameters (with confidence intervals) were as follows: active scan, sensitivity (SN) 52% (34–69%), specificity (SP) 80% (65–91%), negative predictive value (NPV) 73% (58–77%), positive predictive value (PPV) 62% (42–79%), p = 0.002; NAb positivity, SN 71% (45–88%), SP 66% (55–76%), NPV 92% (82–97%), PPV 29% (16–45%), p = 0.01; active scan and NAb positivity, SN 71% (38–91%), SP 86% (73–94%), NPV 94% (86–98%), PPV 50% (29–70%), p = 0.0003. Conclusions: MRI activity and NAb occurrence during the first 6 months of interferon β treatment were reliable predictors of long term clinical response, particularly when combined. Patients with negative predictors showed a less than 10% risk of developing clinical activity. Patients with positive predictors showed a 50% risk of further clinical activity. These patients need to be followed carefully with further MRI and NAb tests.

Currently, most workflow management systems (WfMS) in Grid environments provide push-oriented task distribution strategies, where tasks are directly bound to suitable resources. In those scenarios the dedicated resources execute the submitted tasks according to the request of a WfMS or sometimes by support of a Meta-Scheduling service. This approach has specific problems, especially because of various conditions and constrains that have to be taken into account like local policies or the sites’ autonomy. To deal with such issues, this paper takes a closer look to the task distribution strategies. The established Grid WfMSs essentially support control-flow and data perspectives. However, they neglect the resource perspective. This paper exposes the advantages to deal with this perspective and demonstrates its feasability by a prototype implementation that integrates the missing resource patterns into UNICORE.

Interspecies DNA transfer is a major biological process leading to the accumulation of mutations inherited by sexual reproduction among eukaryotes. Lateral DNA transfer events and their inheritance has been challenging to document. In this study we modified a thermal asymmetric interlaced PCR by using additional targeted primers, along with Southern blots, fluorescence techniques, and bioinformatics, to identify lateral DNA transfer events from parasite to host. Instances of naturally occurring human infections by Trypanosoma cruzi are documented, where mitochondrial minicircles integrated mainly into retrotransposable LINE-1 of various chromosomes. The founders of five families show minicircle integrations that were transferred vertically to their progeny. Microhomology end-joining of 6 to 22 AC-rich nucleotide repeats in the minicircles and host DNA mediates foreign DNA integration. Heterogeneous minicircle sequences were distributed randomly among families, with diversity increasing due to subsequent rearrangement of inserted fragments. Mosaic recombination and hitchhiking on retrotransposition events to different loci were more prevalent in germ line as compared to somatic cells. Potential new genes, pseudogenes, and knockouts were identified. A pathway of minicircle integration and maintenance in the host genome is suggested. Thus, infection by T. cruzi has the unexpected consequence of increasing human genetic diversity, and Chagas disease may be a fortuitous share of negative selection. This demonstration of contemporary transfer of eukaryotic DNA to the human genome and its subsequent inheritance by descendants introduces a significant change in the scientific concept of evolutionary biology and medicine.

After the horizontal transference of kDNA minicircle sequences into the genome of chagasic mammals it was possible to show the heritage of the kDNA mutation into those rabbits breed. However, mammals are permissive to infection by T. cruzi, which may persist through the animal life. To ensure that the kDNA mutation was not only a noise produced by the cryptic infection it was necessary to dismiss this possibility. This was possible through experiments using birds that are refractory to T. cruzi infection but are permissive to infection only in the first 10 days of embryonic life. When the fertile eggs were inoculated with T. cruzi the breed was born without infection but presenting the kDNA mutation. In this regard, rabbits and birds with kDNA mutation presented typical Chagas disease lesions: minimal rejection unit which is characteristic of the pathology of this disease where the non-parasitized target cell was destroyed by the cells from the vertebrate host´s immune system. These experiments showed that the minimal rejection unit is the common denominator of the pathogenesis of Chagas disease in vertebrate animals. In the chicken model refractory to T. cruzi the cardiomegaly was linked to the minimal rejection unit’s inflammatory infiltration. Therefore the parasite-free chicken heart pathology seen in kDNA-mutated chickens could be linked to the genotype and phenotype alterations. The mechanism whereby these alterations induce the immune rejection of the chicken’s heart requires further investigation.